C12N 2750/10062
By genetic engineering
Official title: by genetic engineering
C12N2750/10062 (By genetic engineering) appears on 4 US grants and 7 published applications in this corpus.
Search patents in C12N- Granted patents
- 4
- Published applications
- 7
- Assignees
- 4
- Inventors
- 15
- Latest grant
- 7 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 2 | 1 |
| 2018 | 1 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 0 | 2 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Combination of vaccines to prophylactically treat a pig7 Apr 2026US 12,594,328 B2Intervet Inc.
- Live attenuated chimeric porcine circovirus vaccine2 Jan 2018US 9,855,327 B2Virginia Tech Intellectual Properties, Inc.
- Live attenuated chimeric porcine circovirus vaccine4 Apr 2017US 9,610,344 B2Virginia Tech Intellectual Properties, Inc.
- Live attenuated chimeric porcine circovirus vaccine7 Mar 2017US 9,585,951 B2Virginia Tech Intellectual Properties, Inc.
- Porcine endogenous retrovirus (perv)-free porcine circovirus type 2d-based vaccines and methods of use30 Oct 2025US 2025/0332242 A1Zoetis Services LLC
- Live-attenuated sars-cov-2 vaccine23 Oct 2025US 2025/0325653 A1The U.S.A., as represented by the Secretary, Department of Health and Human Services
- A combination of vaccines to prophylactically treat a pig26 Oct 2023US 2023/0338500 A1Intervet Inc.
- A porcine circovirus type 2 (pcv2) vaccine25 Aug 2022US 2022/0265808 A1
- Live attenuated chimeric porcine circovirus vaccine22 Jun 2017US 2017/0173143 A1Virginia Tech Intellectual Properties, Inc.
Most cited
By later US patents
- Live attenuated chimeric porcine circovirus vaccine2US 9,585,951 B2Virginia Tech Intellectual Properties, Inc. · 2017
- Live attenuated chimeric porcine circovirus vaccine1US 9,610,344 B2Virginia Tech Intellectual Properties, Inc. · 2017
- Live attenuated chimeric porcine circovirus vaccine1US 9,855,327 B2Virginia Tech Intellectual Properties, Inc. · 2018